| Date | Title | Description |
| 17.04.2025 | A New Dawn in Pediatric Health: Ziresovir's Breakthrough Against RSV | In the world of pediatric medicine, a storm brews. Respiratory syncytial virus (RSV) is a formidable foe, striking down infants and young children with relentless ferocity. Each year, millions of cases emerge, leading to countless hospitali... |
| 16.04.2025 | Global Health Innovators recognised with Abu Dhabi Global Health Week Innovation Awards for transformative impact | Winners of the ADGHW Innovation Awards 2025 addressed prenatal gene editing, robotic organ transplantation, precision drug delivery, and novel pain treatments
Recipients include the Children's Hospital of Philadelphia, University of Pennsyl... |
| 16.04.2025 | The Lancet Child & Adolescent Health Publishes Phase III Trial and 24-Month Follow-Up Results of Ziresovir for RSV in Infants Under 6 Months | SHANGHAI, April 16, 2025 /PRNewswire/ -- The Lancet Child & Adolescent Health, a leading international journal in pediatric and adolescent medicine, has published the Phase III clinical trial results of ziresovir, a novel RSV-targeted a... |
| 27.03.2025 | NASA Awards National Stem Cell Foundation $3.1M to Continue Studying Effects of Microgravity on Brain Cells | Kentucky Senate President Robert Stivers and Paula Grisanti, National Stem Cell Foundation CEO, announce a multi-million award from NASA for pioneering space-based research
Funding will Accelerate Commercialization of Flight-proven Research... |
| 10.12.2024 | Business | Bird flu claims 12% of egg supply for major national processor | Egg prices shot up to a national average of nearly $5 a dozen in January 2023 before sharply falling again. They’ve again been rising amid the lingering bird flu cases and high demand during holiday baking season. As of October federal data... |
| 26.11.2024 | ArkBio's Breakthrough in RSV Prevention: A New Hope for Vulnerable Infants | In the world of medicine, every breakthrough is a beacon of hope. Ark Biopharmaceutical Co., Ltd. (ArkBio) has recently illuminated the path forward with its Phase 1 clinical study of AK0610, a monoclonal antibody aimed at preventing respir... |
| 26.11.2024 | The Race Against Obesity and RSV: Innovations in Biotech | In the world of biotechnology, two companies are racing to tackle pressing health issues: obesity and respiratory syncytial virus (RSV). Pep2Tango Therapeutics and ArkBio are making strides that could change the landscape of treatment for m... |
| 25.11.2024 | ArkBio Announces Successful Completion of Enrollment and Dosing for Phase 1 Clinical Study of AK0610, a Preventive Antibody Against Respiratory Syncytial Virus Infection | SHANGHAI, Nov. 25, 2024 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") announced today the successful enrollment and dosing of all participants in a Phase 1 clinical study of AK0610, a fully human monoclonal a... |
| 15.11.2024 | HKUST Welcomes Four Nobel Laureates at the Molecular Frontiers Symposium | Sparking Passion for Science and Innovation Among Young Minds
HONG KONG, Nov. 15, 2024 /PRNewswire/ -- The Hong Kong University of Science and Technology (HKUST) is excited to kick off a prestigious three-day "Molecular Frontiers Sympo... |
| 27.08.2024 | ArkBio Presented at the 8th Annual IPF Summit and Announced Completion of Patient Enrollment for Phase 2 Clinical Trial of AK3280, a Next-Generation Drug for IPF Treatment | BEIJING, Aug. 27, 2024 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio"), a privately held, clinical-stage biopharmaceutical company today announced that Dr. Jim Wu, Chief Executive Officer of ArkBio, gave an ora... |
| 03.06.2024 | Safer, Non-Addictive Chronic Pain Treatment: Researchers Develop Promising Opioid-Free Drug Candidate | By John Lopez
Published Jun 3, 2024 1:04PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard Share on Pocket
A team of researchers from Virginia Commonwealth University (VCU), the University of Texa... |
| 09.05.2024 | Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions | TOKYO, May 9, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.64 billion (USD 10.8 million1) in four projects for the development of new drugs for malaria an... |
| 25.03.2024 | AbbVie Gets Another Ulcerative Colitis Contender via $137M Landos Acquisition | AbbVie already has blockbuster drugs for ulcerative colitis, but that isn’t stopping the pharmaceutical giant from trying to expand its scope in this disease. To that end, the company is acquiring Landos Biopharma, a clinical-stage biotech ... |
| 12.03.2024 | Health | Hidden COVID virus found nearly two years after infection | Pieces of the COVID virus can lurk in our blood and tissue for almost two years after the initial illness has vanished, a discovery that might offer clues to the mystery of lingering post-infection disability, according to new research from... |
| 06.08.2023 | AI System EWAD Can Provide Early Warnings for Dangerous Virus Variants, Scientists Says | Inno Flores, Tech Times 06 August 2023, 10:08 pm
The COVID-19 pandemic has brought immense devastation, but the tireless efforts of scientists and health workers worldwide have mitigated its impact. However, envision a scenario where we cou... |
| 08.06.2023 | Encouraging First-in-Human Results for a Promising HIV Vaccine | Cross-posted from: NIH Director’s Blog
Posted on June 6th, 2023 by Lawrence Tabak, D.D.S., Ph.D. Researchers used a customized nanoparticle (top left) to learn more about guiding the immune system to mount a desired robust response, the typ... |
| 16.03.2023 | Ark Biopharmaceutical and Calibr, a Division of Scripps Research, Announce Co-development Collaboration on AK0705, a Potential First-in-Class Drug for Treating a Broad Spectrum of Respiratory Diseases... | Ark Biopharmaceutical will lead development activities for AK0705 with the goal of initiating clinical studies in 2024.
Calibr will continue to collaborate in the development of AK0705.
The collaboration is an extension of the current co-de... |
| 27.01.2023 | Assessing Impacts of AI on Human Rights: It’s Not Solely About Privacy and Nondiscrimination | That artificial intelligence (AI) systems impact privacy rights has become a kind of truism, often met with a subtle eye roll or a repressed sigh.
The similar concerns about AI and discrimination have not quite become a truism just yet, but... |
| 06.01.2023 | A virologist explains why omicron is continuing to dominate | FOTOGRIN/Shutterstock
Where is the next COVID variant, pi? A virologist explains why omicron is continuing to dominate.,photo: getty images
The omicron variant of SARS-CoV-2, the virus that causes COVID-19, has now been around for more than... |
| 26.10.2022 | Biotech’s newest odd couple: A pharma insider and a music maven launch a health care VC | D.A. Wallach’s first meeting with his business partner could have been the setting of a romantic comedy.
Wallach met Tim Wright in 2018 at a beachside restaurant in Del Mar, Calif., where they dissected the health care industry over seafood... |
| 13.10.2022 | When Will Novavax Vaccines Be FDA Authorized As Covid-19 Boosters? | On September 12, the European Commission authorized the use of the Nuvaxovid Covid-19 vaccine as ... [+] both a homologous and heterologous booster for adults 18 years of age and older. (Photo by Patrick van Katwijk/Getty Images)Getty Image... |
| 03.07.2022 | Two ways life on Mars may be hiding from scientists | Originally Published by:
Three genius iPhone tricks mean you’ll never miss a notification again Rare giant comet making ‘close approach’ to Earth this month – how to watch Wandering star predicted to rain MILLIONS of ‘Doomsday comets’ down ... |
| 29.06.2022 | A Week At The Most Secretive Conference On Aging | Gordon Research Conference (GRC) Systems Aging 2022. Row 1: Vera Gorbunova, Cavin Ward-Caviness, ... [+] Samuel Beck, Sruthi Sivakumar, Vittorio Sebastiano, Steve Horvath, Vadim Gladyshev, Morgan Levine, Daniel Promislow, Brianah McCoy, Ric... |
| 11.04.2022 | Scripps Creates Heart Disease App | Participants in the MyGeneRank app study received their risk score on their smart phones. (Graphic courtesy of Scripps Research) Understanding your genetic risk of coronary artery disease (CAD) artery disease will more likely push you to se... |
| 09.04.2022 | Health Experts Worry That CDC Covid-19 Maps, Measures May Be Misunderstood | A sign at the 2022 Bar & Restaurant Expo and World Tea Conference + Expo recommends face mask ... [+] wearing. Yet, few at the Las Vegas Convention Center are seen covering their noses and mouths. (Photo by David Becker/Getty Images for... |
| 08.02.2022 | Bridge Biotherapeutics and Scripps Research Launch Research Collaboration to Develop Discovery Platform and Novel Covalent Probes Based on Chemical Biology and Chemoproteomics | Two-year research collaboration to develop new reactive group chemistries targeting non-cysteine amino acids to expand druggable binding sites and identify novel targets in oncology and immunology
Collaborators at Scripps are pioneers in th... |
| 11.01.2022 | Enhanced Conolidine: Medical Scientist Clint Winters Announces Patent Filing on CONOCB2™, A Novel Conolidine Pain Relief Active Ingredient with Natural Endocannabinoids | I have watched this powerful ingredient dramatically change lives in our private tests. I am excited to watch it help millions in the years to come as it becomes available worldwide as a legal pain relief ingredient - Clint Winters
ALPHARET... |
| 18.12.2021 | 7 Deaths From Omicron Covid-19 Coronavirus Variant In UK, Showing It’s Not The ‘Omicold’ | Britain's Prime Minster Boris Johnson is seen here during a visit to a Covid-19 vaccination centre ... [+] at Hillingdon Hospital on December 17, 2021 in Uxbridge, England. (Photo by Leon Neal/Getty Images)Getty Images |
| 07.12.2021 | Richard Lerner, antibody pioneer and longtime president of Scripps Research, dies at 83 | Richard Lerner, the esteemed biochemist who pioneered a new way to develop monoclonal antibodies and led Scripps Research Institute to prominence, has passed away.
A spokesperson for Scripps told the San Diego Union-Tribu... |
| 01.12.2021 | Stigma, not science, is the biggest barrier to ending the HIV epidemic | “I am really sorry to reach out like this, David, but I’m worried about my brother. I think he has AIDS.”
I froze when I heard those words a few weeks ago. One reason was because Cheryl was 11 years old the last time I heard her voice; she’... |
| 21.05.2021 | Google Announces New AI App To Diagnose Skin Conditions | Visual examination of the mole for the presence of malignant neoplasms. Prevention for detecting ... [+] skin cancer and melanoma.getty |
| 24.04.2021 | Moderna's mRNA technology could help in the decades-long search for an HIV vaccine | Biotechnology company Moderna protocol files for COVID-19 vaccinations are kept at the Research Centers of America in Hollywood, Florida, on August 13, 2020.
Photo by CHANDAN KHANNA/AFP via Getty Images
Moderna's mRNA tech could change the ... |
| 19.04.2021 | Moderna’s mRNA technology could help in the decades-long search for an HIV vaccine | Biotechnology company Moderna protocol files for COVID-19 vaccinations are kept at the Research Centers of America in Hollywood, Florida, on August 13, 2020. Photo by CHANDAN KHANNA/AFP via Getty Images
Moderna’s mRNA tech could change the ... |
| 21.03.2021 | P.1 Variant, Dominant Strain In Brazil, Reported In New York | |
| 24.02.2021 | Biotech Vividion lands $135M in crossover cash, paving a path to the public markets | The Series C round of financing announced Wednesday included so-called crossover investors, firms that invest in both public and private companies. Securing crossover investment is one of the steps companies take as they prepare for an IPO.... |
| 13.12.2020 | Can Crispr-Based Covid-19 Testing Using Smartphones Slow The Pandemic? | A new CRISPR-based test for COVID-19 developed by researchers at Gladstone Institutes, UC Berkeley, ... [+] and UC San Francisco essentially converts a smartphone camera into a microscope to provide a positive or negative test result and me... |
| 17.11.2020 | Wearable Fitness Trackers Could Help Detect Covid-19 Cases | Results from a large U.S. study suggest that information collected from fitness trackers could help identify who has Covid-19 more accurately than tracking symptoms alone, something the researchers hope will help control the spread of the v... |
| 22.06.2020 | [COVID-19 Update] Mutation Makes Coronavirus More Infectious; Recovered Patients Remain at Risk | CJ Robles, Tech Times 22 June 2020, 08:06 pm
Scientists are worried about a small coronavirus mutation that they have been studying for weeks that, according to them, may make it more infectious.
According to Fox News, a new study which is ... |
| 13.05.2020 | Can fitness trackers warn us about the next COVID-19 attack? | The tiniest changes in your heart rate, temperature, and sleeping patterns could help give forewarning for the next big pandemic.
That’s according to researchers from the wearables company Huami after collecting data from 1.3 million users ... |
| 10.04.2020 | Touchless Economy And Its Post-Pandemic Future | The full potential of touchless economy is yet to be discovered.
Despite the fast-growing tech solutions to tackle COVID-19, EdTech and MedTech still require improvement.
Personal interactions cannot be replaced. At least that’s what the ex... |
| 10.04.2020 | The coronavirus sneaks into cells through a key receptor. Could targeting it lead to a treatment? | Nearly 20 years ago, when a different coronavirus struck, Michael Farzan and his team figured out how it was getting into human cells: targeting a specific receptor called ACE2 found on certain cells.
During this year’s ongoing novel corona... |
| 02.04.2020 | UK tech companies tackling Covid-19 – from detection to vaccination | The 2020 Tech Nation Report revealed that UK healthtech investment has doubled since 2017, reaching £1.7bn in 2019. And this world-leading sector has just become more crucial than ever. Faced with a global pandemic, innovative scaling compa... |
| 25.03.2020 | Scripps Launches App-Based Study Using Wearable Data to Predict Virus Outbreaks | What You Should Know:
– The Scripps Research Translational Institute launched DETECT, an app-based research study that will analyze wearable data shared by users with the goal of being able to more quickly detect fast-spreading viral illnes... |
| 17.07.2019 | 'Reinventing the doctor' is coming up September 12 @UCSF | AI and your doctor; Medicare for All and price controls effect on doctors
At our upcoming salon on September 12, the topic will be "Reinventing the doctor." Keith Rabois, partner at Founders Fund, will be joining us.
Just as Felic... |
| 11.07.2019 | Scripps-led consortium scores $129M NIH grant to work on vaccine for stubborn HIV | Scientific effort into developing a vaccine against the HIV has proved elusive, as the virus rapidly mutates and its outer spike protein operates as an invisibility cloak, allowing it to outwit the immune system’s ... |
| 24.05.2019 | Akrevia scoops ex-Arsanis chief René Russo as CEO; Scott Gottlieb jumps back into industry; Seattle Genetics raids AstraZeneca for CCO | René Russo Akrevia Therapeutics
→ Months after resigning from Arsanis — now relegated to biotech history books after a reverse merger with X4 Pharma — René Russo has landed her next CEO gig at Akrevia Therapeutics. ... |
| 28.02.2019 | Scripps Research explores new model to advance drug development, sustainability | “We wanted to build a new model,” said Schultz in a conference call, “that more effectively bridges the world of basic research and the world of drug discovery that’s historically been the purview of big pharma and biotech.”
These efforts w... |
| 03.01.2019 | Google is quietly infiltrating medicine — but what rules will it play by? | With nearly 80 percent of internet users searching online for health-related information, it’s no wonder the catchphrase “Dr. Google” has caught on, to the delight of many searchers and the dismay of many real doctors.
What’s received littl... |
| 26.11.2018 | Nvidia’s Clara health care platform and medical imaging SDKs hit general availability | Health care remains one of the fastest-growing markets for artificially intelligent (AI) applications and services, with an overall value that’s expected to reach $6.6 billion by 2021. It’s easy to see why: AI systems can analyze ultrasound... |
| 24.10.2018 | NVIDIA pushes further into healthcare with Scripps deep learning research partnership | Deep learning refers to a subset of AI that is analogous to the function of the human brain is able to make determinations and perform contextual reasoning with unstructured data.
The research collaborative is relying on the wider consumer ... |
| 18.09.2018 | 23 potential health benefits of dagga - from pain relief to slowing Alzheimer's | (Unsplash)
SA's Constitutional Court ruled that personal use of dagga is not a criminal offence.
The ruling comes amid new research that shows dagga has significant medical uses.
Benefits of dagga include using it to treat chronic pain, sto... |
| 30.04.2018 | Startup developing semi-synthetic protein therapies raises $63M to tame IL-2 | In the near term, Synthorx is leveraging this technology to tame interleukin-2 (IL-2). Arguably the first immunotherapy, IL-2 boosts the effector T-cells that destroy cancer, offering some patients the opportunity to be cured. Unfortunately... |
| 02.02.2017 | Scripps spin-out Vividion launches with $50M | The startup incorporated in 2013. Since then, it has been operating in stealth mode, a status that was given away earlier this month when it filed a Form D with the SEC as part of its bid to raise just over $50 million.
Vividion’s technolog... |
| 02.02.2017 | ARCH launches Vividion Therapeutics with $50M, ex Celgene exec | ARCH Ventures, Versant and Cardinal Partners have come together in a $50 million Series A raise and launch for upstart Vividion.
The San Diego, CA-based biotech, which will be chaired by former president of global research and early develop... |
| 20.07.2016 | Synthorx receives $10M to pivot toward treatments | The influx of capital will fund a significant evolution at Synthorx, which has been focused on validating their synthetic biology technology. The additional resources will allow them to begin developing treatments, pivoting from a platform ... |
| 21.06.2016 | Science Game Lab to be a central hub for scientists and gamers | Scripps Research is partnering with game studio Playmatics to create a Science Game Lab portal for games that will support citizen science.
The portal’s aim is to get people excited about science through games and gamification of science, o... |
| 21.06.2016 | Harvard astronomer David Charbonneau wins $250,000 award for exoplanet research | Dr. David Charbonneau, a Harvard astronomer known for multiple “firsts” in the field of exoplanet research, has been selected as one of three recipients of the Blavatnik Awards for Young Scientists.
The annual award, which comes with $250,0... |
| 05.11.2015 | Geneticist Craig Venter helped sequence the human genome. Now he wants yours | If you enter Health Nucleus, a new facility in San Diego cofounded by J. Craig Venter, one of the world’s best-known living scientists, you will get a telling glimpse into the state of medical science in 2015.
Your entire genome will be seq... |
| 19.02.2015 | Scientists Discover A New Way To Block HIV | A new HIV-blocking compound may be the answer to the now 30-year search for an AIDS vaccine.
Scientists, supported by the National Institute of Allergy and Infectious Diseases, say they have discovered a new compound that produces proteins ... |
| 15.11.2013 | “Biobetters” startup based on drug discovery tech from Scripps lands $9 million | According to OPKO Health (NYSE:OPK), which said last month it was making an undisclosed strategic investment in the company, Zebra’s platform is an advanced version of a core technology that was crucial to the discovery of AbbVie’s Humira, ... |
| 23.10.2013 | Scripps Translational Science Institute Receives $29M Grant | Scripps Translational Science Institute has received a $29 million grant renewal to explore genomics, wireless technology and bioinformatics.
The National Institutes of Health grant, called the Clinical and Translational Science Award, will... |
| 22.10.2013 | Scripps Translational Science Institute gets $29M from NIH | Dr. Eric Topol
Scripps Translational Science Institute (STSI), the San Diego-based collaboration between Scripps Health and the Scripps Research Institute, has received a $29 million grant from the National Institutes of Health. The grant, ... |
| 26.09.2013 | Meet 5 “genius” MacArthur fellows with visions of shaking up primary care & disease treatment | A data-obsessed primary care physician in one of the most impoverished cities in the U.S.
A neuroscientist turned medical device inventor.
A historian studying a cancer epidemic in Botswana.
These are a few of the two dozen individuals awar... |
| 16.08.2013 | Will the Neil deGrasse Tyson of medicine please stand up? | Atul Gawande
More than 70,000 Twitter followers, writes for the New Yorker, appears from time to time on Colbert Report
@Atul_Gawande
Regina Benjamin
TEDTalks, just left a super-visible position as US Surgeon General, an advocate for health... |
| 02.05.2013 | Merck’s latest Type 2 diabetes deal uses innovative enzyme selection tech | The enzymes at the heart of the technology are referred to as serine hydrolases. Harnessing the power of these enzymes could have broad therapeutic applications since they play an important role in the human physiological processes, such as... |
| 15.03.2012 | Merck research center brings together scientists, entrepreneurs, VCs | Merck (NYSE:MRK) has launched a nonprofit translational research center in San Diego in a move that reflects the dizzy heights of the patent cliffs some Big Pharma companies are facing.
The Whitehouse Station, New Jersey company is providin... |
| 11.01.2011 | MedGadget’s MedTech Monday: Liquid crystal eyeglasses could make bifocals obsolete | Liquid crystal eyeglasses could make bifocals obsolete: Hey, bifocal users, do your glasses give you headaches? Are you straining your eyes trying to see the paper through that tiny reading segment? Are progressive bifocals sooo 2010? There... |
| 28.07.2009 | Qualcomm SSLS: Wireless + Medicine and how the iPhone ties them together | Speaking at Qualcomm’s Smart Services Leadership Summit, Dr. Eric Topol’s introductory presentation is focused on the role of wireless devices in the medical field. Earlier this year at WWDC, Apple demoed the capabilities and value of the i... |
| - | Scripps Research explores new model to advance drug development, sustainability | Scripps Research president and CEO Peter Schultz discusses new funding models at the Spectrum meeting.
Nonprofit research institutes have faced a tough financial road. NIH budgets are stretched, philanthropy is unpredictable and technology ... |
| - | Biotech Vividion lands $135M in crossover cash, paving a path to the public markets | Vividion Therapeutics has technology that finds ways to hit promising disease targets that were previously deemed “undruggable.” Now it has $135 million that might allow it to find something else: a public stock listing.
The Series C round ... |
| - | NVIDIA pushes further into healthcare with Scripps deep learning research partnership | NVIDIA, often considered one of the world’s top AI companies, is pursing its further ambitions in healthcare by teaming up with the Scripps Research Translational Institute to apply deep learning technology to disease prevention.
While the ... |
| - | Meet 5 “genius” MacArthur fellows with visions of shaking up primary care & disease treatment | A data-obsessed primary care physician in one of the most impoverished cities in the U.S.
A neuroscientist turned medical device inventor.
A historian studying a cancer epidemic in Botswana.
These are a few of the two dozen individuals awar... |
| - | Synthorx receives $10M to pivot toward treatments | Synthorx, a synthetic biology company based in San Diego, has received $10 million in series B financing.
The company will use the money to ramp up efforts to develop advanced protein therapeutics based on its synthetic amino acid platform.... |
| - | Scripps spin-out Vividion launches with $50M | There’s a new proteomics platform in town and it has rallied some serious coin.
Vividion Therapeutics launched on Thursday with $50 million in Series A financing led by ARCH Venture Partners and Versant Ventures, with support from founding ... |
| - | “Biobetters” startup based on drug discovery tech from Scripps lands $9 million | A brand new biotech company promising to deliver bio-superior therapeutics for several disease targets has caught the attention of investors, pulling in $9 million in its first investment round.
Zebra Biologics disclosed in a SEC filing thi... |
| - | Merck’s latest Type 2 diabetes deal uses innovative enzyme selection tech | The ongoing effort to develop better drugs to address the $250 billion problem of Type 2 diabetes has a new development. Merck (NYSE: MRK) is collaborating with Abide Therapeutics on three drugs based on a technology platform that selective... |
| - | Will the Neil deGrasse Tyson of medicine please stand up? | There are many inspirational names in modern-day healthcare and, partially due to reform, room for even more. But a commenter on Reddit posed the question of whether there is anyone who is as well-known and charismatic a spokesperson for me... |
| - | Merck research center brings together scientists, entrepreneurs, VCs | Merck (NYSE:MRK) has launched a nonprofit translational research center in San Diego in a move that reflects the dizzy heights of the patent cliffs some Big Pharma companies are facing.
The Whitehouse Station, New Jersey company is providin... |
| - | The Scripps Research Institute and ShangPharma Innovation Announce Translational Research Collaboration | La Jolla, California (June 8, 2017) – The Scripps Research Institute (TSRI) and ShangPharma Innovation, Inc. (SPII) today announced a strategic collaboration to accelerate the development of innovative drug candidates through scientific col... |
| - | Ученые добавили еще две «буквы» к генетическому «алфавиту» — и они работают | Ученые добавили еще две «буквы» к генетическому «алфавиту» — и они работают
03 Декабря, 2017, 15:00
Ольга Карпенко
10107
1
Живые организмы на Земле хранят свои «чертежи» в ДНК, на базе четырех азотистых оснований — аденина (А), гуанина (Г),... |
| - | Startup developing semi-synthetic protein therapies raises $63M to tame IL-2 | San Diego-based Synthorx has brought in $63 million in Series C financing to advance its efforts to produce semi-synthetic protein therapies for cancer and immune conditions. The funding round was led by OrbiMed with others such as Medicxi,... |
